The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Stryker has finalized its acquisition of Amplitude Vascular Systems (AVS), a medical technology firm focused on developing an intravascular lithotripsy (IVL) platform. This strategic move aims to accelerate the commercialization and global expansion of AVS's specialized solutions for treating severely calcified arterial lesions. Integration with Stryker will provide AVS with broader distribution channels, resources, and clinical expertise to strengthen its competitive position in the global market. While financial terms were not disclosed, industry experts view the deal as a significant enhancement to Stryker’s peripheral vascular portfolio. The acquisition positions Stryker to better serve the growing demand for minimally invasive treatments in interventional cardiology. This development reflects a broader trend of consolidation and innovation within the high-growth healthcare technology sector.
Sign in to access this content
Sign In